Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 4/20 | 0.63 |
| ▸ | NPC1 | O15118 | 3/20 | 0.63 |
| ▸ | HPGD | P15428 | 2/20 | 0.63 |
| ▸ | CRHBP | P24387 | 1/20 | 0.63 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.63 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | TSHR | P16473 | 2/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | RECQL | P46063 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.54 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.54 |
| ▸ | HTT | P42858 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzene SCHEMBL11603590 | 0.96 | RAB9A (0.69) | RAB9ANPC1HPGDCRHBPCRHR2 | |
| SCHEMBL7565510 | 0.92 | RAB9A (0.71) | RAB9ANPC1HPGDCRHBPCRHR2 | |
| SCHEMBL11406432 | 0.87 | RAB9A (0.55) | RAB9ANPC1HPGDCRHBPCRHR2 | |
| SCHEMBL11790359 | 0.86 | RAB9A (0.65) | RAB9ANPC1HPGDCRHBPCRHR2 | |
| SCHEMBL1719720 | 0.86 | SMN1; SMN2 (0.71) | RAB9ANPC1HPGDCRHBPCRHR2 | |
| SCHEMBL9146676 | 0.86 | LMNA (0.68) | RAB9ANPC1HPGDCRHBPCRHR2 | |
| SCHEMBL7565512 | 0.86 | RAB9A (0.70) | RAB9ANPC1HPGDCRHBPCRHR2 | |
| SCHEMBL18025700 | 0.86 | GAA (0.50) | RAB9ANPC1HPGDCRHBPCRHR2 | |
| SCHEMBL9126654 | 0.85 | KMT2A (0.59) | RAB9ANPC1HPGDCRHBPCRHR2 | |
| SCHEMBL19390510 | 0.85 | SMN1; SMN2 (0.67) | RAB9ANPC1HPGDCRHBPCRHR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 509 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117865613-A | Thermal insulation leveling material and construction method thereof | 四川华诺邦环保科技有限公司 | 2024-04-12 | — | — | CN | claimed |
| CN-117776602-A | Preparation method for preparing geopolymer cement from lepidolite extracted lithium tailings | 江西九岭锂业股份有限公司 | 2024-03-29 | — | — | CN | claimed |
| US-20220186037-A1 | COATED PARTICLES FOR TURF INFILL | PREFERRED TECHNOLOGY, LLC | 2022-06-16 | — | — | US | claimed |
| EP-3506873-B1 | PERSONAL CARE GEL AND METHOD | COLGATE PALMOLIVE CO (US) | 2021-11-03 | — | — | EP | claimed |
| US-20190209442-A1 | Personal Care Gel and Method | COLGATE-PALMOLIVE COMPANY (US) | 2019-07-11 | — | — | US | claimed |
| EP-3506873-A1 | PERSONAL CARE GEL AND METHOD | Colgate-Palmolive Company (US) | 2019-07-10 | — | — | EP | claimed |
| WO-2018056989-A1 | PERSONAL CARE GEL AND METHOD | COLGATE-PALMOLIVE COMPANY (US) | 2018-03-29 | — | — | WO | claimed |
| EP-1904020-B1 | SLIMMING COSMETIC COMPOSITIONS | SEDERMA SA (FR) | 2016-10-26 | — | — | EP | claimed |
| US-20100291007-A1 | Administration of extracts of nonfruiting nonphotosynthetic filamentous bacteria for increasing the endogenous synthesis of superoxide dismutase | SOCIETE L'OREAL S.A. (FR) | 2010-11-18 | — | — | US | claimed |
| WO-2010044076-A2 | COSMETIC AND TOPICAL USE OF XANTHOHUMOL INCLUDING BRIGHTENING SKIN COMPLEXION AND REDUCING CUTANEOUS REDNESS | SEDERMA (FR) | 2010-04-22 | — | — | WO | claimed |
| CN-1079393-C | Aminophenol derivatives and their use in cosmetics | OREAL (FR) | 2002-02-20 | — | — | CN | claimed |
| US-20010053350-A1 | Cosmetic composition comprising N-ethyloxycarbonyl-4-amino-phenol and arbutin or its derivatives and/or ellagic acid or its derivatives | L'OREAL (FR) | 2001-12-20 | — | — | US | claimed |
| WO-2001072767-A1 | DEHYDROEPIANDROSTERONE DERIVATIVES, PREPARATION METHOD AND USES THEREOF, IN PARTICULAR FOR COSMETICS | L'OREAL (FR) | 2001-10-04 | — | — | WO | claimed |
| EP-1110537-A2 | Cosmetic composition comprising N-ethoxycarbonyl-4-aminophenol and arbutin or its derivatives and/or ellagic acid or its derivatives | L'OREAL (FR) | 2001-06-27 | — | — | EP | claimed |
| EP-1110538-A2 | Cosmetic composition comprising an aminophenol derivative | L'OREAL (FR) | 2001-06-27 | — | — | EP | claimed |
| EP-1092423-A2 | Use of DHEA or its precursors and metabolites as skin depigmentation agents | L'OREAL (FR) | 2001-04-18 | — | — | EP | claimed |
| EP-0966434-A1 | AMINOPHENOL DERIVATIVES AND THEIR USE IN COSMETICS | L'OREAL (FR) | 1999-12-29 | — | — | EP | claimed |
| CN-1237155-A | Aminophenol derivatives and their use in cosmetics | OREAL (FR) | 1999-12-01 | — | — | CN | claimed |
| WO-1999010318-A1 | AMINOPHENOL DERIVATIVES AND THEIR USE IN COSMETICS | L'OREAL (FR) | 1999-03-04 | — | — | WO | claimed |
| US-4775704-A | MIXTURE OF ORGANIC AND CERAMIC BINDERS, CURING AGENTS AND SAND | NAGAHORI TEIJI (JP) | 1988-10-04 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010053350-A1 | Cosmetic composition comprising N-ethyloxycarbonyl-4-amino-phenol and arbutin or its derivatives and/or ellagic acid or its derivatives | TYR, MITF, CUTA | RAB9A 2284/4885NPC1 3200/4885HPGD 748/4885 |
| US-20190209442-A1 | Personal Care Gel and Method | CUTA, GLMN, ISG15 | RAB9A 4872/4885NPC1 4795/4885HPGD 1085/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.